Current Edition

Current Features

How Managing the Simple Medical Device Label Could Make or Break Nordic Expansion Ambitions for Manufacturers

The Nordic region is a potentially lucrative area for medical device companies to expand into, with analyst research estimating Sweden alone to have a 2.7% …

Continue Reading →
Current Features

Will Universal Pharmacare be Introduced in Canada?

Prescription drug insurance in Canada is provided by a mixture of government and private plans. Government plans offer coverage to about a quarter of the …

Continue Reading →
Current Features

The Big Debate: Will Quality Management Still Exist in 2025?

Late last year, visionaries from Merck, Syneos Health and Accenture took part in a live video debate on what now influences the way life sciences …

Continue Reading →
Current Features

Reasons Why Flexibility is the Secret to Pharma Success in 2022

Ben Wylie at ChargePoint Technology looks back on key learnings from 2021 for cleanroom pharmaceutical manufacturing. He explores why flexibility is key to overcoming sterile …

Continue Reading →
Current Features

Accelerating Asia’s Digital cGXP Transformation with Industry 4.0 Technologies

Across Asia, pharma leaders are working hard to accelerate their Industry 4.0 digital transformation and, in the process, ensure current Good Practice (cGXP) compliance. IDC …

Continue Reading →
Current Features

Roundtable: The Continuing Evolution of Bioinformatics in the Pharma Industry

In life sciences, research, advances in instrumentation, new types of measurements that are now possible and improved computational tools are generating not only significantly more …

Continue Reading →
Current Features

Improving Outcomes for Gastric Cancer Patients via a Novel Oral Daily Dose Chemotherapy Formulation, Oncoral

Gastric cancer is the fifth most common cancer, with around one million annual incidences worldwide, and it represents the fourth most common cause of cancer …

Continue Reading →
Current Features

The Enigma of Topical Biologics Development

Traditionally, most marketed drugs, irrespective of their route of delivery, have had relatively low molecular weights. Nowhere has this been more markedly true than in …

Continue Reading →
Current Features

Study Coordinators Speak Out on Trial Site Diversity: 4 Ways to Move the Needle

In recent years, a consensus has grown around the concern that clinical trials in the United States are neither adequately inclusive nor diverse. For example, …

Continue Reading →
Current Features

Tackling the Challenges with Decentralised Trials

Decentralised clinical trials (DCTs) have existed for years in different shapes and forms. Urged by the COVID-19 pandemic, restrictions to in-person patient visits and other …

Continue Reading →